[ad_1]
Jiangsu implements the new version of the National Drug List, the annual cost of drugs from 10,560 yuan to 860.4 yuan
Meeting Point News From March 1, Jiangsu Province will implement the new version of the medical insurance drug catalog. The total number of drugs is 2,800, including 1,264 Western drugs, 1,315 Chinese proprietary drugs, 221 drugs traded during the agreement period, and 892 Chinese drugs that can be paid for by the fund.
An important feature of this adjustment is the large number of drugs shortlisted for the negotiation of price reductions. A total of 119 drugs have been added to the list, and outpatient special diseases have reached 17. The burden of medical care for Jiangsu urban employees, urban and rural residents and other insured persons will be further reduced.
Through negotiations, a total of 10 new first-class drugs developed by local Jiangsu companies were listed in the national health insurance catalog, including 1 systemic antiviral drug, 1 diabetes drug, 1 nervous system drug, 7 antitumor drugs and more involved in insurance Patients can share the innovative achievements of Jiangsu medicine.
“At present, the latest hospital drug information system has been successfully changed, and patients can go to the hospital health insurance inquiry window to learn the latest situation,” said Jiang Zhiwei, vice president of Provincial Hospital of Traditional Chinese Medicine of Jiangsu. and chief physician of general surgery. The prices of drugs that are needed for clinical treatments such as cancer, chronic diseases and childhood diseases and that are used more frequently have been drastically reduced. “
Jiang Zhiwei set an example to reporters in combination with his own clinical medication. The original price of a Budegefu inhalation spray that chronic pulmonary obstruction patients must use for a long time is 880 yuan per tube and is not covered by health insurance. Patients must pay 880 on their own for one year. Yuan / piece * 12 pieces = 10560 yuan. This time, the drug entered the new version of the drug catalog at a negotiated price of 239 yuan / unit, and the proportion of self-pay of insured in Nanjing was 30%. Now, if the patient uses this drug, the annual cost is 239 yuan / bottle * 12 pieces * 30% = 860.4 yuan, which is not enough for the original price of a drug, and it has really become a cheap medicine for ordinary people. .
According to Han Hongyu, the second-level inspector of the Jiangsu Health Insurance Bureau, compared to the previous adjustment of the drug catalog, the new catalog negotiated more pre-selected price reduction drugs, benefiting a wide range of treatment areas. The average price of the 119 newly transferred drugs was reduced by 50.64%, including 96 exclusive drugs and 23 non-exclusive drugs, involving 31 clinical groups, representing 86% of all clinical groups.
In order to better guarantee the necessary drugs for the treatment of the new coronary pneumonia, the new version of the catalog will also include the injection of ribavirin, Arbidol granules and other drugs. Until now, all medications listed in the latest version of the National Plan for the Diagnosis and Treatment of New Coronary Pneumonia have been covered by medical insurance.
To ensure that the new version of the catalog is implemented as soon as possible on March 1, the Jiangsu Provincial Medical Safety Office and the Provincial Health and Health Commission held a special video conference on the implementation of the 2020 version of the national drug. catalog in the province on February 26, and the specific deployment of the catalog was clarified All localities must implement the new version of the management of the catalog of medicines without commitment, and further consolidate the main responsibility of medical institutions for national negotiation of medications. Strictly implement the provisions of the national catalog, do not formulate the catalog yourself or use flexible methods to add drugs to the catalog, and it is not allowed to adjust varieties, dosage forms and limit the scope of payment in the drug catalog in any name . During the agreement period, the negotiated drug districts and cities will determine their self-pay rate and reimbursement rate based on the affordability of the fund. In principle, the proportion of drugs negotiated at the national level will not exceed 30%. , and no second negotiation is allowed during the deal.
It is understood that the Jiangsu health insurance department will make reasonable adjustments to the annual total number of medical institutions based on the actual use of drugs in medical institutions, while optimizing coordination clauses and includes the reasonable deployment of medical institutions and the use of drugs in the medical insurance catalog in the management content of the agreement. Encourage all localities to innovate working methods and methods, and promote the implementation of drug catalogs by improving outpatient guarantee policies, opening the designated pharmacy channels of health insurance, and rationally adjusting total control. At the same time, designated medical institutions are required to equip and use negotiated drugs in a timely manner according to their own medical characteristics and needs, in order to “make the most of what needs to be done and take advantage of everything.” and achieve “the need for energy supply and energy supply”.
Xinhua Newspaper Reporter from the meeting point Huang Hongfang
Copyright and disclaimer
Copyright Statement: All manuscripts whose source is “Meeting Point, Xinhua Daily and its sub-papers” or whose electronic heading is “Xinhua Newspaper Net” are exclusive copyrights of Xinhua Newspaper Net. No reprinting or duplication without permission; reprint is authorized The source should be listed as “Xinhua Newspaper Network” and the power head of “Xinhua Newspaper Network” should be kept.
Disclaimer: Manuscripts reprinted on this site only represent the personal opinions of the author and have nothing to do with Xinhua Newspaper.com. This site has not verified the originality, text and content indicated in the article. This site makes no guarantees or promises regarding the authenticity, completeness and topicality of this article, all or part of the content and text. Readers are invited for reference only, and check the relevant content yourself.
